Greenland Mines Finalizes $38.4M Direct Offering at $12/Share with Pre-Funded Warrants
GRML has more than doubled off its 52-week low of $2.82 on elevated volume (8.1× avg).
Summary
Greenland Mines priced a $38.4M direct offering at $12.00 per share with pre-funded warrants for 1.43M more shares, nearly doubling its August raise to fund mining operations amid going concern and delisting pressures.
Updates
· Dow Jones Newswires — Shares rose 10% to $12.35 in after-hours trading following the pricing, recovering from a 21% drop during the regular session.
Key Events · Financing and Capital Events · GRML
-
$38.4M Direct Offering Priced at $12.00
Registered direct offering of 1,765,420 common shares plus pre-funded warrants for 1,434,580 shares at $12.00 per share, expected to close September 24, 2026.
-
Pre-Funded Warrant Structure
Warrants exercisable at $0.0001 per share with 9.99% (or 4.99% at election) beneficial ownership blockers; no expiration until fully exercised.
-
Dilution Impact
Fully-exercised share count rises from 8.83M to 12.03M — roughly 36% dilution to existing holders. Pro forma net tangible book value of $3.96 per share vs $12.00 offering price.
-
Use of Proceeds
Up to $40M earmarked for Greenland mining operations; balance for general corporate and working capital purposes.
Analysis · GRML · Life Sciences
Greenland Mines priced a $38.4 million registered direct offering at $12.00 per share — nearly double its August $20M raise at $5.00 — with pre-funded warrants for 1.43M additional shares. The deal provides critical runway amid going concern doubts and a Nasdaq delisting deadline, but dilutes existing holders by roughly 36% on a fully-exercised basis. The offering price sits below the $14.15 last reported sale price on September 22, 2026, and well below today's $12.29, reflecting the company's distressed capital position.
How filings like this one have moved
In the 30 days to Nov 3, 2026, 40.9% of the 1143 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.37%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GRML was trading at $12.29 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $35.6M. The 52-week trading range was $2.82 to $36.99. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.